Biomea Fusion, Inc. financial data

Symbol
BMEA on Nasdaq
Location
San Carlos, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 04 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 304% % -43%
Debt-to-equity 113% % 321%
Return On Equity -310% % -161%
Return On Assets -145% % -55%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 70,703,639 shares 95%
Common Stock, Shares, Outstanding 59,508,518 shares 64%
Entity Public Float $124,145,240 USD -79%
Common Stock, Value, Issued $6,000 USD 50%
Weighted Average Number of Shares Outstanding, Basic 59,848,325 shares 65%
Weighted Average Number of Shares Outstanding, Diluted 59,848,325 shares 65%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $79,104,000 USD -36%
General and Administrative Expense $20,558,000 USD -26%
Operating Income (Loss) $101,867,000 USD 33%
Net Income (Loss) Attributable to Parent $95,711,000 USD 34%
Earnings Per Share, Basic -2 USD/shares 40%
Earnings Per Share, Diluted -2 USD/shares 40%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $46,642,000 USD -47%
Assets, Current $49,440,000 USD -47%
Property, Plant and Equipment, Net $200,000 USD -95%
Operating Lease, Right-of-Use Asset $5,178,000 USD -32%
Other Assets, Noncurrent $0 USD -100%
Assets $55,187,000 USD -50%
Accounts Payable, Current $6,397,000 USD -29%
Employee-related Liabilities, Current $2,938,000 USD -48%
Liabilities, Current $15,565,000 USD -44%
Operating Lease, Liability, Noncurrent $6,089,000 USD -11%
Liabilities $39,568,000 USD 15%
Retained Earnings (Accumulated Deficit) $453,660,000 USD -27%
Stockholders' Equity Attributable to Parent $15,619,000 USD -79%
Liabilities and Equity $55,187,000 USD -50%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $25,667,000 USD 20%
Net Cash Provided by (Used in) Financing Activities $3,252,000 USD 2703%
Net Cash Provided by (Used in) Investing Activities $0 USD
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 59,508,518 shares 64%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $22,415,000 USD 30%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $47,011,000 USD -47%
Deferred Tax Assets, Valuation Allowance $113,866,000 USD 59%
Deferred Tax Assets, Gross $115,905,000 USD 55%
Operating Lease, Liability $8,771,000 USD -15%
Depreciation $1,896,000 USD 15%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $95,711,000 USD 34%
Lessee, Operating Lease, Liability, to be Paid $12,172,000 USD -24%
Property, Plant and Equipment, Gross $1,162,000 USD -85%
Operating Lease, Liability, Current $787,000 USD -71%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,526,000 USD -45%
Lessee, Operating Lease, Liability, to be Paid, Year One $2,903,000 USD -28%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 9.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3,401,000 USD -24%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,443,000 USD 4.6%
Deferred Tax Assets, Operating Loss Carryforwards $48,853,000 USD 55%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $3,914,000 USD 77%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,474,000 USD 3%
Operating Lease, Payments $2,269,000 USD 66%
Additional Paid in Capital $469,273,000 USD 8.1%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $2,039,000 USD -33%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%